Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder
NCT06934915Phase 1Recruiting
- Start
- Aug 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing Prednisone with Placebo (2 arms). Primary endpoint: Clinical Global Impressions-Improvement at 10 weeks. Started Aug 2026; status: recruiting.
02
Drugs
prednisone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT06934915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06934915.